01/02/2005
ReGen Therapeutics Plc (the ‘Company’) announces that on 31 January 2005 it received notification from Mr P. Garrod that he is beneficially interested in 36,000,000 ordinary shares of the Company representing 10.5% of the current issued share capital of the Company.
For further information, please contact:
Andrew Marshall
Marshall Robinson Roe
Tel. 020 7960 6007